Latest raise
$173M
Date raised
November 17, 2026
Round
Series A
InvestorsScion Life Sciences, venBio
Websitewww.marrowtx.com
About Gabriel Mullokandov
an experimental treatment for sickle cell disease and beta thalassemia that aims to deliver genetic medicines directly to bone marrow cells.
- Who is Gabriel Mullokandov?
- Gabriel Mullokandov is listed as Co-founder of Marrow Therapeutics, a biotechnology company.
- How much did Marrow Therapeutics raise?
- Marrow Therapeutics raised $173M in a Series A round on November 17, 2026 (5 days ago). Backed by Scion Life Sciences, venBio.
Get newly funded founders every week
A free weekly list of startups that just raised.